Connectus Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Connectus Wealth’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$2.2M	Buy	40,472 +14,693	+57%	+$748K	0.06%	173
2023 Q4	$1.32M	Buy	25,779 +4,791	+23%	+$251K	0.03%	306
2023 Q3	$1.22M	Buy	20,988 +1,485	+8%	+$91K	0.03%	297
2023 Q2	$1.25M	Buy	19,503 +4,209	+28%	+$282K	0.03%	263
2023 Q1	$1.06M	Sell	15,294 -18,902	-55%	-$1.33M	0.03%	280
2022 Q4	$2.46M	Sell	34,196 -43,408	-56%	-$3.27M	0.06%	195
2022 Q3	$5.53M	Buy	77,604 +2,436	+3%	+$177K	0.12%	173
2022 Q2	$5.8M	Sell	75,168 -232	-0.3%	-$17.7K	0.13%	140
2022 Q1	$4.71M	Sell	75,400 -4,707	-6%	-$316K	0.15%	109
2021 Q4	$5M	Buy	+80,107	New	+$4.7M	0.19%	77

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connectus Wealth's BMY Position: Q1 2024 in Review

Connectus Wealth increased its Bristol-Myers Squibb (BMY) stake by 57% in Q1 2024, buying an estimated $748K and bringing the position to 40,472 shares worth $2.2M. The position accounts for 0.06% of the portfolio, ranked #173.

Connectus Wealth first reported a position in BMY in Q4 2021 and has held it in 10 quarters since. The position peaked at $5.8M in Q2 2022. 2,331 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Connectus Wealth held 40,472 shares of Bristol-Myers Squibb worth $2.2M as of Q1 2024.
Connectus Wealth bought 14,693 Bristol-Myers Squibb shares in Q1 2024, an estimated $748K.
Bristol-Myers Squibb made up 0.06% of Connectus Wealth's portfolio in Q1 2024, its #173 holding.
Connectus Wealth first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 10 quarters since.
Connectus Wealth's Bristol-Myers Squibb position peaked at $5.8M in Q2 2022.
2,331 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.